111 Capital’s Johnson & Johnson JNJ Stock Holding History

111 Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,937	Closed	-$1.45M	–	561
2026 Q1	$1.45M	Sell	5,937 -2,479	-29%	-$577K	0.36%	56
2025 Q4	$1.74M	Buy	+8,416	New	+$1.66M	0.38%	47
2025 Q3	–	Sell	-12,474	Closed	-$1.91M	–	586
2025 Q2	$1.91M	Buy	12,474 +6,045	+94%	+$929K	0.33%	62
2025 Q1	$1.07M	Sell	6,429 -2,134	-25%	-$334K	0.21%	111
2024 Q4	$1.24M	Buy	+8,563	New	+$1.33M	0.26%	77

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

111 Capital's JNJ Position: Q2 2026 in Review

111 Capital sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 5,937 shares — an estimated $1.45M sold.

111 Capital first reported a position in JNJ in Q4 2024 and held it in 5 quarters. The position peaked at $1.91M in Q2 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

111 Capital reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
111 Capital sold 5,937 Johnson & Johnson shares in Q2 2026, an estimated $1.45M.
111 Capital first reported a position in Johnson & Johnson in Q4 2024 and held it in 5 quarters.
111 Capital's Johnson & Johnson position peaked at $1.91M in Q2 2025.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.